Expressable Raises $26M Series B to Expand Access to its Technology-Enabled Speech Therapy Solution
Summary
Funding will accelerate Expressables market leadership and growing partnerships with leading health plan and provider groupsAUSTIN, Texas, May 21, 2024 /PRNewswire/ -- , the market leader in research-based, family-centered speech therapy care, announced today it raised $26 million in Series B funding led by global investment firm HarbourVest Partners, with participation from Digitalis Ventures and existing investors F-Prime Capital and Lerer Hippeau.The financing will support efforts to enhance the companys technology-enabled care delivery platform, expand their clinical network of W2-employed speech-language pathologists, and accelerate a growing roster of health plan and provider partnerships across the country. "Speech therapy has transformational impacts on a childs life, yet too many children today are left severely underserved risking delayed outcomes and cost-intensive care," said President and Chief Clinical Officer Leanne Sherred, M.S. "Were grateful to HarbourVest and all of our investors for sharing in our mission of reinventing the current standard of care, a critical endeavor given speech therapys tremendous impact on healthy childhood development. Children with speech and language impairment suffer increased risk of learning disabilities, behavioral disorders, poor academic achievement, and impacts on socio-emotional health.Expressable integrates virtual services with its comprehensive education and technology platform, empowering caregivers to incorporate therapy techniques into the home for faster positive outcomes and more cost-effective care. Expressable has pioneered a family-centered and research-based care model that uses technology and education to integrate speech therapy techniques into childrens daily lives, improving outcomes and experiences.